Products
By Team
Sales
Multithread effectively and personalize outreach to convert deals faster
Social Media Marketing
Elevate social presence and drive business growth from social media
RevOps
Identify and prioritize high-intent leads, and improve sales effectiveness
Events & Field Marketing
Find and connect with ICP attendees, and improve event outcomes
Resources
.png)
.png)
Talaris Therapeutics
What Does Talaris Therapeutics Do?
Talaris Therapeutics, Inc. was a clinical-stage cell therapy company dedicated to developing FCR001, an innovative allogeneic cell therapy aimed at establishing durable immune tolerance in patients. The company's research primarily targeted organ transplant rejection, severe autoimmune diseases, and certain immune-mediated hematologic conditions. In a significant strategic shift, Talaris Therapeutics completed a reverse merger with Tourmaline Bio, Inc. in October 2023. The merged entity now operates as Tourmaline Bio, concentrating on the development of TOUR006 for thyroid eye disease and atherosclerotic cardiovascular disease.
Where Is Talaris Therapeutics's Headquarters?
HQ Function
Served as the primary center for Talaris's executive leadership, corporate strategy, clinical development oversight, financial operations, and administrative functions.
Notable Features:
The headquarters was situated in a modern office building within Boston's renowned biopharmaceutical cluster, offering proximity to leading research institutions, collaborators, and a skilled talent pool.
Work Culture:
As a clinical-stage biotechnology firm, Talaris likely fostered a scientifically driven, innovative, and patient-focused work culture, emphasizing collaboration and a commitment to addressing unmet medical needs.
HQ Significance:
The Boston headquarters was strategically vital, enabling Talaris to leverage the rich biotech ecosystem for partnerships, talent acquisition, and investor relations.
Values Reflected in HQ: The choice of location and the company's mission underscored values such as innovation, scientific excellence, and a deep commitment to improving patient outcomes.
Location:
Before merging with Tourmaline Bio, Talaris Therapeutics's operational activities, including R&D and manufacturing, were primarily based in the United States. Its 'global' reach was mainly characterized by its clinical trial sites, which were predominantly located within the U.S. as it advanced its therapies through the regulatory pathway.
Street Address:
222 Berkeley Street, 16th Floor
City:
Boston
State/Province:
MA
Country:
USA
Where Else Does Talaris Therapeutics Operate Around the World?
Louisville, KY, USA
Address: 950 S. First Street, Louisville, KY 40203
The Louisville location was chosen for its specific operational capabilities suitable for advanced cell therapy manufacturing and its logistical advantages for supporting clinical studies across the U.S.
Buying Intent Signals for Talaris Therapeutics
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Who's Leading Talaris Therapeutics? Meet the Executive Team
As of April 2025, Talaris Therapeutics' leadership includes:
Who's Investing in Talaris Therapeutics?
Talaris Therapeutics has been backed by several prominent investors over the years, including:
What Leadership Changes Has Talaris Therapeutics Seen Recently?
The 12-month period leading up to mid-2024 was marked by significant transitions for Talaris Therapeutics, culminating in its October 2023 reverse merger with Tourmaline Bio. This phase involved several executive departures and role changes as the company restructured and wound down its standalone operations. Notably, Talaris's CFO, Mary Kay Fenton, assumed the role of interim CEO before the merger, and subsequently became CEO of the new combined entity, Tourmaline Bio.
Departures
New Appointments:
What Technology (Tech Stack) Is Used byTalaris Therapeutics?
Discover the tools Talaris Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Talaris Therapeutics Email Formats and Examples
Prior to its merger and subsequent operational wind-down, Talaris Therapeutics likely utilized standard corporate email address formats. The most common format for companies of its type is [first_initial][last]@[domain_name], for example, jdoe@talaristx.com. Other potential formats include [first].[last]@[domain_name]. These email addresses are no longer active.
[first_initial][last]@talaristx.com
Format
mkayfenton@talaristx.com
Example
70%
Success rate
What's the Latest News About Talaris Therapeutics?
GlobeNewswire • October 19, 2023
Talaris Therapeutics and Tourmaline Bio Announce Closing of Merger
Talaris Therapeutics and Tourmaline Bio, Inc. confirmed the successful completion of their merger. The combined entity now operates as Tourmaline Bio, Inc., trading under 'TRML', and will focus on advancing Tourmaline’s lead program, TOUR006....more
GlobeNewswire • July 26, 2023
Talaris Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results
Talaris announced plans for a further workforce reduction to approximately 10 employees by the end of Q3 2023, alongside the continued wind-down of its legacy programs and reaffirmation of the pending merger with Tourmaline Bio....more
GlobeNewswire • June 22, 2023
Talaris Therapeutics Enters Into Definitive Merger Agreement with Tourmaline Bio
Talaris Therapeutics revealed it had signed a definitive merger agreement with Tourmaline Bio, Inc. The merged company plans to concentrate on Tourmaline’s pipeline, supported by a concurrent $75 million private placement by Tourmaline investors....more
Fierce Biotech • February 16, 2023
Talaris cuts a third of staff, halts phase 3 trial after patient death, explores 'strategic alternatives'
Talaris Therapeutics announced a major restructuring, including a workforce reduction of about one-third, the discontinuation of its Phase 3 FREEDOM-1 study in living donor kidney transplant patients, and a halt to its Phase 2 FREEDOM-2 study, while initiating a process to explore strategic alternatives....more
Highperformr's free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Talaris Therapeutics, are just a search away.